SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 203 filers reported holding SAGE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $361,922 | -80.0% | 17,586 | -54.4% | 0.00% | -50.0% |
| Q2 2023 | $1,812,761 | +4.3% | 38,553 | -7.0% | 0.00% | 0.0% |
| Q1 2023 | $1,738,822 | -4.6% | 41,440 | -13.3% | 0.00% | -33.3% |
| Q4 2022 | $1,821,952 | -5.8% | 47,770 | -3.3% | 0.00% | 0.0% |
| Q3 2022 | $1,934,000 | +8.8% | 49,385 | -10.2% | 0.00% | 0.0% |
| Q2 2022 | $1,777,000 | -20.0% | 55,018 | -18.1% | 0.00% | 0.0% |
| Q1 2022 | $2,222,000 | +15.0% | 67,144 | +47.8% | 0.00% | 0.0% |
| Q4 2021 | $1,933,000 | -22.0% | 45,442 | -18.7% | 0.00% | -25.0% |
| Q3 2021 | $2,478,000 | -22.4% | 55,918 | -0.5% | 0.00% | -20.0% |
| Q2 2021 | $3,192,000 | -13.4% | 56,186 | +14.2% | 0.01% | -16.7% |
| Q1 2021 | $3,684,000 | -37.9% | 49,219 | -28.3% | 0.01% | -45.5% |
| Q4 2020 | $5,936,000 | +63.0% | 68,621 | +15.2% | 0.01% | +57.1% |
| Q3 2020 | $3,642,000 | +101.8% | 59,588 | +37.2% | 0.01% | +75.0% |
| Q2 2020 | $1,805,000 | +162.4% | 43,428 | +82.1% | 0.00% | +100.0% |
| Q1 2020 | $688,000 | -80.3% | 23,852 | -50.6% | 0.00% | -71.4% |
| Q4 2019 | $3,487,000 | +89.0% | 48,305 | +268.9% | 0.01% | +40.0% |
| Q3 2019 | $1,845,000 | -47.4% | 13,095 | -32.0% | 0.01% | -44.4% |
| Q2 2019 | $3,508,000 | +15.5% | 19,260 | -0.1% | 0.01% | 0.0% |
| Q1 2019 | $3,037,000 | +526.2% | 19,278 | +282.7% | 0.01% | +350.0% |
| Q4 2018 | $485,000 | -47.3% | 5,037 | -22.3% | 0.00% | -33.3% |
| Q3 2018 | $921,000 | -4.3% | 6,482 | +5.7% | 0.00% | 0.0% |
| Q2 2018 | $962,000 | +139.9% | 6,133 | +22.7% | 0.00% | +200.0% |
| Q2 2017 | $401,000 | -94.9% | 4,998 | -96.8% | 0.00% | -97.7% |
| Q1 2015 | $7,939,000 | +38.7% | 158,036 | +57.6% | 0.04% | +34.4% |
| Q4 2014 | $5,725,000 | – | 100,261 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
| Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
| Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
| Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
| DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
| Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
| Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
| SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
| Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
| Diametric Capital, LP | 19,393 | $626,000 | 0.46% |